Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study

被引:495
作者
Parle, JV
Maisonneuve, P
Sheppard, MC
Boyle, P
Franklyn, JA
机构
[1] Univ Birmingham, Div Primary Care Publ & Occupat Hlth, Birmingham, W Midlands, England
[2] Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England
[3] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy
关键词
D O I
10.1016/S0140-6736(01)06067-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Low serum thyrotropin, in combination with normal concentrations of circulating thyroid hormones, is common, especially in elderly people and in individuals with a history of thyroid disease. We aimed to assess the long-term effects of subclinical hyperthyroidism on mortality. Methods We did a population-based study of mortality in a cohort of 1191 individuals not on thyroxine or antithyroid medication. All participants were aged 60 years or older. We measured concentration of thyrotropin in serum at baseline in 1988-89. We recorded vital status on June 1, 1999, and ascertained causes of death for those who had died. We compared data for causes of death with age-specific, sex-specific, and year-specific data for England and Wales. We also compared mortality within the cohort according to initial thyrotropin measurement. Results During 9733 person-years of follow-up, 509 of 1191 people died, the expected number of deaths being 496 (standardised mortality ratio [SMR] 1.0, 95% CI 0.9-1.1). Mortality from all causes was significantly increased at 2 (SMR 2.1), 3 (2.1), 4 (1.7), and 5 (1.8) years after first measurement in those with low serum thyrotropin (n=71). These increases were largely accounted for by significant increases in mortality due to circulatory diseases (SMR 2.1, 2.2, 1.9, 2.0, at years 2, 3, 4, and 5 respectively). Increases in mortality from all causes in years 2-5 were higher in patients with low serum thyrotropin than in the rest of the cohort (hazard ratios for years 2, 3, 4, and 5 were 2.1, 2.2, 1.8, and 1.8, respectively). This result reflects an increase in mortality from circulatory diseases (hazard ratios at years 2, 3, 4, and 5 were 2.3, 2.6, 2.3, 2.3), and specifically from cardiovascular diseases (hazard ratios at years 2, 3, 4, and 5 were 3.3, 3.0, 2.3, 2.2). Interpretation A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases.
引用
收藏
页码:861 / 865
页数:5
相关论文
共 17 条
  • [1] Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine
    Biondi, B
    Fazio, S
    Cuocolo, A
    Sabatini, D
    Nicolai, E
    Lombardi, G
    Salvatore, M
    Sacca, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) : 4224 - 4228
  • [2] CONTROL OF ADRENERGIC OVERACTIVITY BY BETA-BLOCKADE IMPROVES THE QUALITY-OF-LIFE IN PATIENTS RECEIVING LONG-TERM SUPPRESSIVE THERAPY WITH LEVOTHYROXINE
    BIONDI, B
    FAZIO, S
    CARELLA, C
    SABATINI, D
    AMATO, G
    CITTADINI, A
    BELLASTELLA, A
    LOMBARDI, G
    SACCA, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) : 1028 - 1033
  • [3] CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE
    BIONDI, B
    FAZIO, S
    CARELLA, C
    AMATO, G
    CITTADINI, A
    LUPOLI, G
    SACCA, L
    BELLASTELLA, A
    LOMBARDI, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) : 334 - 338
  • [4] Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis
    Ching, GW
    Franklyn, JA
    Stallard, TJ
    Daykin, J
    Sheppard, MC
    Gammage, MD
    [J]. HEART, 1996, 75 (04) : 363 - 368
  • [5] THE SIGNIFICANCE OF TSH VALUES MEASURED IN A SENSITIVE ASSAY IN THE FOLLOW-UP OF HYPERTHYROID PATIENTS TREATED WITH RADIOIODINE
    DAVIES, PH
    FRANKLYN, JA
    DAYKIN, J
    SHEPPARD, MC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) : 1189 - 1194
  • [6] SCREENING FOR THYROID-DISEASE IN A PRIMARY CARE UNIT WITH A THYROID STIMULATING HORMONE ASSAY WITH A LOW DETECTION LIMIT
    EGGERTSEN, R
    PETERSEN, K
    LUNDBERG, PA
    NYSTROM, E
    LINDSTEDT, G
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6663) : 1586 - 1592
  • [7] Mortality after the treatment of hyperthyroidism with radioactive iodine
    Franklyn, JA
    Maisonneuve, P
    Sheppard, MC
    Betteridge, J
    Boyle, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) : 712 - 718
  • [8] THYROTOXICOSIS AND THE HEART - SOMETHING OLD AND SOMETHING NEW
    LADENSON, PW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) : 332 - 333
  • [9] MORBIDITY IN PATIENTS ON L-THYROXINE - A COMPARISON OF THOSE WITH A NORMAL TSH TO THOSE WITH A SUPPRESSED TSH
    LEESE, GP
    JUNG, RT
    GUTHRIE, C
    WAUGH, N
    BROWNING, MCK
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (06) : 500 - 503
  • [10] PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77